Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review.
SSc
U11/U12
autoantibodies
interstitial lung disease
systemic sclerosis
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
27 Mar 2023
27 Mar 2023
Historique:
received:
11
02
2023
revised:
08
03
2023
accepted:
09
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Anti-nuclear (ANA) are present in approximately 90% of systemic sclerosis (SSc) patients and are key biomarkers in supporting the diagnosis and determining the prognosis of this disease. In addition to the classification criteria autoantibodies for SSc [i.e., anti-centromere, anti-topoisomerase I (Scl-70), anti-RNA polymerase III], other autoantibodies have been associated with important SSc phenotypes. Among them, anti-U11/U12 ribonucleoprotein (RNP) antibodies, also known as anti-RNPC-3, were first reported in a patient with SSc, but very little is known about their association and clinical utility. The U11/U12 RNP macromolecular complex consists of several proteins involved in alternative mRNA splicing. More recent studies demonstrated associations of anti-anti-U11/U12 antibodies with SSc and severe pulmonary fibrosis as well as with moderate to severe gastrointestinal dysmotility. Lastly, anti-U11/U12 autoantibodies have been strongly associated with malignancy in SSc patients. Here, we aimed to summarize the knowledge of anti-U11/U12/RNPC-3 antibodies in SSc, including their seroclinical associations in a narrative literature review.
Identifiants
pubmed: 37046475
pii: diagnostics13071257
doi: 10.3390/diagnostics13071257
pmc: PMC10093660
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Respir Res. 2023 Jan 9;24(1):6
pubmed: 36624431
Autoimmun Rev. 2009 Mar;8(5):373-8
pubmed: 19103309
Arthritis Rheumatol. 2022 Mar;74(3):518-526
pubmed: 34514739
Arthritis Res Ther. 2012 Mar 06;14(2):R50
pubmed: 22394602
RMD Open. 2020 Sep;6(2):
pubmed: 32892170
Arthritis Rheum. 2003 Feb 15;49(1):85-92
pubmed: 12579598
J Rheumatol. 2014 Jul;41(7):1334-43
pubmed: 24931955
N Engl J Med. 2019 Jun 27;380(26):2518-2528
pubmed: 31112379
J Rheumatol. 2017 Dec;44(12):1938-1939
pubmed: 29196548
Arthritis Res Ther. 2013 Apr 12;15(2):R50
pubmed: 23587095
Arthritis Res Ther. 2011;13(5):R172
pubmed: 22018289
Autoimmun Rev. 2020 Aug;19(8):102583
pubmed: 32553611
Arthritis Care Res (Hoboken). 2014 Apr;66(4):575-84
pubmed: 24023044
Rheumatology (Oxford). 2018 Apr 1;57(4):712-717
pubmed: 29294089
Arthritis Rheumatol. 2017 Jun;69(6):1306-1312
pubmed: 28217959
Autoimmun Rev. 2015 Mar;14(3):254-7
pubmed: 25462581
Ther Adv Musculoskelet Dis. 2021 Jul 27;13:1759720X211032457
pubmed: 34377160
Arthritis Res Ther. 2021 Jun 1;23(1):155
pubmed: 34074331
Autoimmun Rev. 2011 Feb;10(4):194-200
pubmed: 20933614
Ther Adv Musculoskelet Dis. 2022 Aug 22;14:1759720X221116408
pubmed: 36051631
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6781-5
pubmed: 8341699
Clin Rev Allergy Immunol. 2022 Oct;63(2):178-193
pubmed: 35040083
Arthritis Rheum. 2002 Dec;46(12):3266-72
pubmed: 12483731
Clin Rev Allergy Immunol. 2022 Oct;63(2):210-239
pubmed: 35258843
RNA. 2004 Jun;10(6):929-41
pubmed: 15146077
EMBO J. 2005 Sep 7;24(17):3057-69
pubmed: 16096647
Front Immunol. 2021 May 27;12:679613
pubmed: 34122443
Wiley Interdiscip Rev RNA. 2013 Jan-Feb;4(1):61-76
pubmed: 23074130
Arthritis Rheum. 2009 Jul 15;61(7):958-65
pubmed: 19565553
Ann Rheum Dis. 2022 Dec;81(12):1722-1729
pubmed: 35973804
RNA. 2018 Dec;24(12):1856-1870
pubmed: 30254136
Arthritis Care Res (Hoboken). 2019 Sep;71(9):1164-1170
pubmed: 30242973
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7526-E7534
pubmed: 27821747
Clin Immunol. 2003 May;107(2):65-79
pubmed: 12763475
Arthritis Rheum. 1989 Sep;32(9):1165-9
pubmed: 2789047
J Appl Lab Med. 2022 Jan 5;7(1):322-330
pubmed: 34996073
Ann Rheum Dis. 2021 Feb;80(2):219-227
pubmed: 32988845
Autoimmun Rev. 2008 Sep;7(8):588-93
pubmed: 18617021
J Rheumatol. 2010 Oct;37(10):2071-5
pubmed: 20682663
Ann Rheum Dis. 2021 Jul;80(7):912-919
pubmed: 33495152
Arthritis Res Ther. 2005;7(3):R704-13
pubmed: 15899056
Autoimmun Rev. 2007 Aug;6(7):432-7
pubmed: 17643929
Front Immunol. 2015 Apr 15;6:167
pubmed: 25926833
J Autoimmun. 2023 Feb;135:102988
pubmed: 36634459
Autoimmun Rev. 2009 Jun;8(7):632-7
pubmed: 19393201
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S131-5
pubmed: 26315678
Arthritis Rheum. 2003 Jan;48(1):210-7
pubmed: 12528121
Eur Respir J. 2020 May 14;55(5):
pubmed: 32079645
Rheumatology (Oxford). 2021 Dec 24;61(1):154-162
pubmed: 33742673
Clin Rev Allergy Immunol. 2022 Jun 18;:
pubmed: 35716254
Immunol Res. 2021 Jun;69(3):239-248
pubmed: 33913080
Ann N Y Acad Sci. 2007 Aug;1109:311-21
pubmed: 17785320
Rheumatology (Oxford). 2022 Oct 12;:
pubmed: 36222557
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Nat Commun. 2021 Sep 14;12(1):5417
pubmed: 34521836